Search Within

Ross Levine

Formats
  1. Journal Article (386)
  2. Meeting Abstract (343)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (10)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (774)
  2. Center for Hematologic Malignancies (774)
  3. Department of Medicine (774)
  4. Executive Committee, Center for Hematologic Malignancies (774)
  5. GSK Faculty (774)
  6. Hematologic Malignancies, Division of (774)

More Groups

People
  1. Omar Abdel-Wahab (166)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (69)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (5)
  2. 2024 (32)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (289)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Nature Publishing Group (107)
  3. American Association for Cancer Research (67)
  4. Cell Press (47)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (22)

More Publishers

Results (774)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Guiding the global evolution of cytogenetic testing for hematologic malignancies
    Guidelines

    Akkari, Y. M. N.; Baughn, L. B.; Dubuc, A. M.; Smith, A. C.; Mallo, M.; Dal Cin, P.; Diez Campelo, M.; Gallego, M. S.; Granada Font, I.; Haase, D. T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The hematopoietic saga of clonality in sickle cell disease
    Journal Article

    Stonestrom, A. J.; Levine, R. L.
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Reduced plasmacytoid dendritic cell output is associated with high risk in low-grade myelodysplastic syndrome
    Research Letter

    Chan, A.; Liu, Y.; Devlin, S.; Gao, Q.; Baik, J.; Sigler, A.; Londono, D.; Arcila, M.; Levine, R.; Dogan, A.; more...
    HemaSphere (2022)

    Fulltext@MSK | Save
  • ASXL1 loss cooperates with oncogenic NRAS in mice to reprogram the immune microenvironment and drive leukemic transformation
    Journal Article

    You, X.; Liu, F.; Binder, M.; Vedder, A.; Lasho, T.; Wen, Z.; Gao, X.; Flietner, E.; Rajagopalan, A.; Zhou, Y.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • ERK2 substrate binding domains perform opposing roles in pathogenesis of a JAK2V617F-driven myeloproliferative neoplasm
    Meeting Abstract

    Truong, B.; Zhang, Y.; Fahl, S.; Qcai, K.; Martinez, E.; Al-Saleem, E.; Gong, Y.; Liebermann, D.; Soboloff, J.; Dunbrack, R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Gilteritinib (GILT) monotherapy with addition of decitabine (DEC) in non-responders in older newly diagnosed (ND) FLT3 mutated acute myeloid leukemia (AML) patients having high and low variant allele frequency (VAF): A phase 2/1b sub-study of the Beat AML Master Trial
    Meeting Abstract

    Traer, E.; Huang, Y.; Mims, A. S.; Stein, E. M.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W.; Arellano, M. L.; Schiller, G. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Ivosidenib (IVO) in combination with azacitidine (AZA) in newly diagnosed (ND) older patients with IDH1 R132-mutated acute myeloid leukemia (AML) induces high response rates: A phase 2 sub-study of the beat AML master trial
    Meeting Abstract

    Patel, P.; Ruppert, A. S.; Borate, U.; Stein, E. M.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W.; Arellano, M. L.; Schiller, G. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Allogeneic transplantation in fit older adults is feasible and encouragingly efficacious. Post remission data from the prospective ECOG-ACRIN (E2906) clinical study
    Meeting Abstract

    Ofran, Y.; Sun, Z.; Rowe, J. M.; Claxton, D. F.; Tallman, M. S.; Arber, D. A.; Melnick, A.; Levine, R. L.; Paietta, E.; Godwin, J. E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clonotype-immunophenotype relationships in TET2 and IDH-mutant myeloid transformation
    Meeting Abstract

    Miles, L. A.; Bowman, R. L.; Delgaudio, N.; Robinson, T.; Carroll, M. P.; Meyer, S. E.; Levine, R. L.
    Blood (2021)

    Fulltext@MSK | Save
  • The BMP/SMAD pathway is a key mediator of leukemic transformation of TP53-mutant post-MPN AML
    Meeting Abstract

    Li, B.; An, W.; Wang, H.; Krishnan, A.; Mowla, S.; Baslan, T.; Koche, R.; Xiao, W.; Lowe, S.; Levine, R. L.; more...
    Blood (2021)

    Fulltext@MSK | Save